Anling Hu
Impact in
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
-
- Tryptophan and brain disorders
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Retinoids in leukemia and cellular processes 2
-
- Atherosclerosis and Cardiovascular Diseases 2
- Co-authors
- Jie Liu (6 shared papers)Shangfu Xu (7 shared papers)Qin Wu (2 shared papers)Jiajia Liu (1 shared paper)Lu Xie (1 shared paper)Babu Gajendran (13 shared papers)Wuling Liu (14 shared papers)Yaacov Ben‐David (15 shared papers)
- Journals
- BMC Cancer (3 papers)Journal of Ethnopharmacology (3 papers)Biomedicine & Pharmacotherapy (3 papers)Medical Oncology (2 papers)Cell Death Discovery (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Anling Hu
25 papers receiving 272 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 46
- Biological Psychiatry 12
- Complementary and alternative medicine 29
- Neurology 18
- Molecular Biology 134
Countries citing papers authored by Anling Hu
This map shows the geographic impact of Anling Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anling Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anling Hu more than expected).
Fields of papers citing papers by Anling Hu
This network shows the impact of papers produced by Anling Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anling Hu. The network helps show where Anling Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Anling Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 51 | |
| 2 | 2019 | 34 | |
| 3 | 2020 | 25 | |
| 4 | 2019 | 21 | |
| 5 | 2020 | 21 | |
| 6 | 2021 | 18 | |
| 7 | 2019 | 12 | |
| 8 | 2018 | 12 | |
| 9 | 2021 | 11 | |
| 10 | 2020 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2022 | 4 |
About Anling Hu
Anling Hu is a scholar working on Molecular Biology, Immunology, Hematology, Cancer Research and Oncology, having authored 27 papers that have together received 277 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Heavy Metal Exposure and Toxicity (3 papers), Traditional Chinese Medicine Analysis (3 papers), Cancer-related molecular mechanisms research (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer, Lipids, and Metabolism (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). The work is most often cited by research in Pharmacology (46 citations), Biological Psychiatry (12 citations), Complementary and alternative medicine (29 citations), Neurology (18 citations) and Molecular Biology (134 citations). Anling Hu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Jie Liu, Shangfu Xu, Qin Wu, Jiajia Liu, Lu Xie, Babu Gajendran, Wuling Liu, Yaacov Ben‐David, Bin‐Bin Zhang and Huan Li. Their work appears in journals such as BMC Cancer, Journal of Ethnopharmacology, Biomedicine & Pharmacotherapy, Medical Oncology and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.